Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1681-1688

  Batteux, Frédéric ^a,b   Lores, Patrick ^a   Bucchini, Danièle ^a   Chiocchia, Gilles ^a,b  

^a INSERM   (France)

^b Université Paris Descartes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; THYROGLOBULIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; HASHIMOTO DISEASE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID FOLLICLE CELL; THYROID GLAND; TRANSGENE;

EID: 0034651608     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1681     Document Type: Article

References (48)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
2. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
3. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
4. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
5. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
6. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
7. Drappa, J., A. K. Vaishnaw, K. E. Sullivan, J. L. Chu, and K. B. Elkon. 1996. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335:1643.
8. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
9. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
10. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
11. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7.
12. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363.
13. Braley-Mullen, H., M. Johnson, G. C. Sharp, and M. Kyriakos. 1985. Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell. Immunol. 93:132.
14. Michiels, F. M., B. Caillou, M. Talbot, F. Dessarps-Freichey, M. T. Maunoury, M. Schlumberger, L. Mercken, R. Monier, and J. Feunteun. 1994. Oncogenic potential of guanine nucleotide stimulatory factor α subunit in thyroid glands of transgenic mice. Proc. Natl. Acad. Sci. USA 91:10488.
15. Batteux, F., L. Tourneur, H. Trebeden, J. Charreire, and G. Chiocchia. 1999. Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand. J. Immunol. 162:603.
16. Allison, J., H. M. Georgiou, A. Strasser, and D. L. Vaux. 1997. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA 94:3943.
17. Kang, S. M., D. B. Schneider, Z. Lin, D. Hanahan, D. A. Dichek, P. G. Stock, and S. Baekkeskov. 1997. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738.
18. Kang, S. M., Z. Lin, N. L. Ascher, and P. G. Stock. 1998. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplant. Proc. 30:538.
19. Chervonsky, A. V., Y. Wang, F. S. Wong, I. Visintin, R. A. Flavell, C. A. Janeway, Jr., and L. A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell 89:17.
20. Stassi, G., R. De Maria, G. Trucco, W. Rudert, R. Testi, A. Galluzzo, C. Giordano, and M. Trucco. 1997. Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193.
21. Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960.
22. Arscott, P. L., J. Knapp, M. Rymaszewski, J. L. Bartron, J. D. Bretz, N. W. Thompson, and J. R. Baker, Jr. 1997. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 138:5019.
23. Arscott, P. L., and J. R. Baker, Jr. 1998. Apoptosis and thyroiditis. Clin. Immunol. Immunopathol. 87:207.
24. Dayan, C. M., K. A. Elsegood, and R. Maile. 1997. FasL expression on epithelial cells: the Bottazzo-Feldman hypothesis revisited. Immunol. Today 18:203.
25. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188:415.
26. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7:255.
27. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293.
28. + T cells specific for a pancreatic β cell neo-antigen. Immunity 2:573.
29. Renno, T., M. Hahne, J. Tschopp, and H. R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183:431.
30. + T cell deletion. Immunity 3:321.
31. Zhang, L., R. G. Miller, and J. Zhang. 1996. Characterization of apoptosis-resistant antigen-specific T cells in vivo. J. Exp. Med. 183:2065.
32. Rocha, B., A. Grandien, and A. A. Freitas. 1995. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181:993.
33. Tang, H., K. Mignon-Godefroy, P. L. Meroni, G. Garotta, J. Charreire, and F. Nicoletti. 1993. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur. J. Immunol. 23:275.
34. Mignon-Godefroy, K., O. Rott, M. P. Brazillet, and J. Charreire. 1995. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT): evidence for IL-10-enhanced cell death in EAT. J. Immunol. 154:6634.
35. Mignon-Godefroy, K., M. P. Brazillet, O. Rott, and J. Charreire. 1995. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis." Cell. Immunol. 162:171.
36. Batteux, F., H. Trebeden, J. Charreire, and G. Chiocchia. 1999. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur. J. Immunol. 29:958.
37. Alimi, E., S. Huang, M. P. Brazillet, and J. Charreire. 1998. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-γ receptor gene. Eur. J. Immunol. 28:201.
38. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
39. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545.
40. Varadhachary, A. S., S. N. Perdow, C. Hu, M. Ramanarayanan, and P. Salgame. 1997. Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. USA 94:5778.
41. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837.
42. McSorley, S. J., S. Soldera, L. Malherbe, C. Carnaud, R. M. Locksley, R. A. Flavell, and N. Glaichenhaus. 1997. Immunological tolerance to a pancreatic antigen as a result of local expression of TNFα by islet β cells. Immunity 7:401.
43. Charreire, J. 1989. Immune mechanisms in autoimmune thyroiditis. Adv. Immunol. 46:263.
44. Ozdemirli, M., M. El-Khatib, L. C. Foote, J. K. Wang, A. Marshak-Rothstein, T. L. Rothstein, and S. T. Ju. 1996. Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses. Eur. J. Immunol. 26:415.
45. Lagresle, C., P. Mondiere, C. Bella, P. H. Krammer, and T. Defrance. 1996. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J. Exp. Med. 183: 1377.
46. Wang, J., I. Taniuchi, Y. Maekawa, M. Howard, M. D. Cooper, and T. Watanabe. 1996. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 26:92.
47. Elkon, K. B., and A. Marshak-Rothstein. 1996. B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. Curr. Opin. Immunol. 8:852.
48. Akkaraju, S., K. Canaan, and C. C. Goodnow. 1997. Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J. Exp. Med. 186:2005.